↓ Skip to main content

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine

Overview of attention for article published in Frontiers in Pharmacology, November 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
Published in
Frontiers in Pharmacology, November 2019
DOI 10.3389/fphar.2019.01302
Pubmed ID
Authors

Ming-Fen Ho, Cheng Zhang, Lingxin Zhang, Hu Li, Richard M Weinshilboum

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 18%
Student > Ph. D. Student 6 12%
Other 5 10%
Student > Master 5 10%
Student > Doctoral Student 4 8%
Other 6 12%
Unknown 15 30%
Readers by discipline Count As %
Neuroscience 10 20%
Biochemistry, Genetics and Molecular Biology 8 16%
Agricultural and Biological Sciences 6 12%
Medicine and Dentistry 5 10%
Immunology and Microbiology 1 2%
Other 6 12%
Unknown 14 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2023.
All research outputs
#15,242,689
of 25,483,400 outputs
Outputs from Frontiers in Pharmacology
#5,090
of 19,844 outputs
Outputs of similar age
#199,556
of 381,650 outputs
Outputs of similar age from Frontiers in Pharmacology
#186
of 407 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,844 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,650 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 407 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.